2015
DOI: 10.21276/apjhs.2015.2.1.31
|View full text |Cite
|
Sign up to set email alerts
|

Development of Sustained Release Drug Delivery System: A Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(19 citation statements)
references
References 8 publications
0
14
0
1
Order By: Relevance
“…The marketed topical products containing clindamycin are in solution and gel form, but they are meant to focus more on treating acne than the long-term inflammation associated with HS on the skin of patients. Moreover, there are some limitations observed on the conventional dosage forms, for instance, the necessity of frequent administration, especially for the drug with short half-life, fluctuations of the drug levels [ 23 ], as well as the higher chance of cross-contamination on the applicator. The approach for this study is to consider a formulation that could possess bioadhesion and a sustained-release effect to enhance the residence time for the drug at the site of skin, as the inflammation associated with HS stage I and mild stage II is mainly present at the epidermis and upper dermis layer [ 8 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The marketed topical products containing clindamycin are in solution and gel form, but they are meant to focus more on treating acne than the long-term inflammation associated with HS on the skin of patients. Moreover, there are some limitations observed on the conventional dosage forms, for instance, the necessity of frequent administration, especially for the drug with short half-life, fluctuations of the drug levels [ 23 ], as well as the higher chance of cross-contamination on the applicator. The approach for this study is to consider a formulation that could possess bioadhesion and a sustained-release effect to enhance the residence time for the drug at the site of skin, as the inflammation associated with HS stage I and mild stage II is mainly present at the epidermis and upper dermis layer [ 8 ].…”
Section: Discussionmentioning
confidence: 99%
“…A combination of both natural and synthetic polymers can be used in the formulation to achieve the ideal condition. Some of the main advantages of in situ gel formulations include a sustained-release drug delivery system, ease of administration, reduction in the frequency of application, improvement in steady levels [ 23 ], and moreover, the prevention in cross-contamination as the formulation would be administered in spray form, meaning no contact was necessary on the applicator.…”
Section: Discussionmentioning
confidence: 99%
“…Polimer alami seperti polisakarida, gum, kitosan, dan alginat dapat membentuk suatu spherical microbeads yang berpotensi sebagai alternatif penghantaran obat menjadi bentuk perilisan terkontrol (83,84) . Tujuan dari pelepasan terkontrol adalah untuk menjaga konsentrasi obat pada level yang tetap dalam periode waktu tertentu, untuk menurunkan frekuensi pemberian dosis, meningkatkan level keamanan dari obat, meningkatkan tingkat kepatuhan pasien, menurunkan fluktuasi, menurunkan efek samping lokal dan sistemik (85) , serta memperlama durasi aksi obat, dan memastikan respon farmakokinetik dan farmakodinamik dapat reprodusibel dan diprediksi. Selain itu, polimer dapat pula dimodifikasi sedemikian rupa untuk menjadi sistem penghantaran obat tertarget pada organ tertentu (83) .…”
Section: Pemanfaatan Kombinasi Polimerunclassified
“…Many oldest dosage forms suspension, emulsion, tablet capsules, suppositories, etc. have a few drawbacks, like drugs having a short half-life need repeated drug administration, which increases the like hood of skipping a dose of a drug resulting in fewer patient compliance [8]. Drug's steady-state level cannot be maintained in the body because of peak-valley due to absorption and elimination of the drug from the body and this would lead to underdose or overdose, as uniform drug amount increases or decrease above the range of therapeutic.…”
Section: Sustained-release Drug Deliverymentioning
confidence: 99%